Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: DUPAGE MEDICAL TECHNOLOGY INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2016-11-15 to 2020-02-14
Current total value of award: $1958172.98
Description: DEVELOPING AN INHIBITOR OF INTEGRIN OUTSIDE-IN SIGNALING AS A NEW GENERATION OF ANTI-THROMBOTIC DRUG - VITA 2